IMUX vs GILD: Which Stock is Better?
Side-by-side comparison of Immunic Inc and Gilead Sciences Inc in 2026
IMUX
Immunic Inc
$1.00
GILD
Gilead Sciences Inc
$137.64
Key Metrics Comparison
| Metric | IMUX | GILD | Winner |
|---|---|---|---|
| Market Cap | $130.46M | $170.84B | GILD |
| P/E Ratio | N/A | 20.27 | GILD |
| EPS (TTM) | $N/A | $6.79 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze IMUX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMUX or GILD a better investment?
Comparing IMUX and GILD: Immunic Inc has a market cap of $130.46M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMUX and GILD?
IMUX (Immunic Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMUX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMUX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for IMUX.
Which company is more profitable: IMUX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for IMUX.
Which is the larger company: IMUX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $130.46M for IMUX.
Should I buy IMUX or GILD in 2026?
Both IMUX and GILD have investment merit. IMUX trades at $1.00 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMUX and GILD stock?
Key differences: Market Cap ($130.46M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).